Literature DB >> 20414157

Methylphenidate effect in children with ADHD can be measured by an ecologically valid continuous performance test embedded in virtual reality.

Yehuda Pollak1, Hanan Barhoum Shomaly, Patrice L Weiss, Albert A Rizzo, Varda Gross-Tsur.   

Abstract

BACKGROUND: Continuous performance tasks (CPTs) embedded in a virtual reality (VR) classroom environment have been shown to be a sensitive and user-friendly assessment tool to detect cognitive deficits related to attention-deficit/hyperactivity disorder (ADHD). The aim of the current study was to compare the performance of children with ADHD on a VR-CPT while on and off treatment with methylphenidate (MPH) and to compare the VR-CPT to a currently used CPT, Test of Variables of Attention (TOVA).
METHODS: Twenty-seven children with ADHD underwent the VR-CPT, the same CPT without VR (no VR-CPT), and the TOVA, 1 hour after the ingestion of either placebo or 0.3 mg/kg MPH, in a double-blind, placebo-controlled, crossover design. Immediately following CPT, subjects described their subjective experiences on the Short Feedback Questionnaire.
RESULTS: MPH reduced omission errors to a greater extent on the VR-CPT compared to the no VR-CPT and the TOVA, and decreased other CPT measures on all types of CPT to a similar degree. Children rated the VR-CPT as more enjoyable compared to the other types of CPT.
CONCLUSIONS: It is concluded that the VR-CPT is a sensitive and user-friendly assessment tool in measuring the response to MPH in children with ADHD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414157     DOI: 10.1017/s109285290002736x

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  9 in total

Review 1.  A Comparison of Virtual Reality Classroom Continuous Performance Tests to Traditional Continuous Performance Tests in Delineating ADHD: a Meta-Analysis.

Authors:  Thomas D Parsons; Tyler Duffield; Justin Asbee
Journal:  Neuropsychol Rev       Date:  2019-06-03       Impact factor: 7.444

Review 2.  The usefulness of virtual, augmented, and mixed reality technologies in the diagnosis and treatment of attention deficit hyperactivity disorder in children: an overview of relevant studies.

Authors:  Saeideh Goharinejad; Samira Goharinejad; Sadrieh Hajesmaeel-Gohari; Kambiz Bahaadinbeigy
Journal:  BMC Psychiatry       Date:  2022-01-04       Impact factor: 3.630

3.  Prenatal supplementation with DHA improves attention at 5 y of age: a randomized controlled trial.

Authors:  Usha Ramakrishnan; Ines Gonzalez-Casanova; Lourdes Schnaas; Ann DiGirolamo; Amado D Quezada; Beth C Pallo; Wei Hao; Lynnette M Neufeld; Juan A Rivera; Aryeh D Stein; Reynaldo Martorell
Journal:  Am J Clin Nutr       Date:  2016-09-07       Impact factor: 7.045

4.  Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status.

Authors:  Yu-Shu Huang; Liang-Jen Wang; Chih-Ken Chen
Journal:  BMC Psychiatry       Date:  2012-11-09       Impact factor: 3.630

Review 5.  Virtual Reality for Enhanced Ecological Validity and Experimental Control in the Clinical, Affective and Social Neurosciences.

Authors:  Thomas D Parsons
Journal:  Front Hum Neurosci       Date:  2015-12-11       Impact factor: 3.169

Review 6.  The opportunities of virtual reality in the rehabilitation of children with attention deficit hyperactivity disorder: a literature review.

Authors:  Azadeh Bashiri; Marjan Ghazisaeedi; Leila Shahmoradi
Journal:  Korean J Pediatr       Date:  2017-11-27

7.  Virtual Reality Assessment of Classroom - Related Attention: An Ecologically Relevant Approach to Evaluating the Effectiveness of Working Memory Training.

Authors:  Benjamin Coleman; Sarah Marion; Albert Rizzo; Janiece Turnbull; Anne Nolty
Journal:  Front Psychol       Date:  2019-08-20

8.  Evaluating attention deficit hyperactivity disorder symptoms in children and adolescents through tracked head movements in a virtual reality classroom: The effect of social cues with different sensory modalities.

Authors:  Yoon Jae Cho; Jung Yon Yum; Kwanguk Kim; Bokyoung Shin; Hyojung Eom; Yeon-Ju Hong; Jiwoong Heo; Jae-Jin Kim; Hye Sun Lee; Eunjoo Kim
Journal:  Front Hum Neurosci       Date:  2022-08-04       Impact factor: 3.473

9.  A Virtual Home for the Virtual Clinical Trial.

Authors:  Susan Persky
Journal:  J Med Internet Res       Date:  2020-01-03       Impact factor: 5.428

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.